RxDoctor Payments Data

Scott Thompson, PA

Physician Assistant · Saint Clair Shores, MINPI 1417909987

Payments from drug & device makers

$1,399in general payments, 2019–2025

Across 15 payments — averaging $93.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$241
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$224
  • AbbVie$161
  • Vanda Pharmaceuticals Inc.$125
  • Supernus Pharmaceuticals, Inc.$125
  • Collegium Pharmaceutical, Inc.$125
  • plus $399 from 4 others

What the payments were for

  • Food & beverage$1,28892%
  • Education$1118%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,399 in reported general payments places this provider in the 80th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$58,189
Medicare patients
274
Services billed
511

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate18$136,614
VraylarCariprazine Hcl18$25,585
Duloxetine Hcl164$6,212
Olanzapine82$4,815
Memantine Hcl121$3,183
Quetiapine Fumarate117$2,706
Escitalopram Oxalate157$2,247
Mirtazapine55$1,611
Trazodone Hcl127$1,469
Buspirone Hcl94$1,469
Divalproex Sodium48$1,468
Sertraline Hcl132$1,368
Desvenlafaxine Succinate ErDesvenlafaxine Succinate28$1,206
Risperidone69$1,185
Paroxetine Hcl61$1,155

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$161$25,58518 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Saint Clair Shores

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →